Israeli medical device offers new Alzheimer’s treatment
Food Drug Administration in late 2014.
Neuronix CEO Eyal Baror poses for a photo next to a newly developed device to treat Alzheimer’s disease at Assaf Harofeh Medical Center near Tel uk canada goose outlet Aviv October Canada Goose online 24, 2012. Canada Goose Coats On Sale REUTERS/Nir Elias
The device, which combines electromagnetic stimulation with computer based cognitive training, is already canada goose uk shop approved for use in Europe, Israel and several Asian countries such as canada goose uk black friday Singapore.
stimulate the brain on Canada Goose Jackets a biological level as well as on a cognitive level, Neuronix CEO Eyal Baror told Reuters, saying this double approach https://www.thecanadagooseoutlet.com created longer lasting benefits.
The device, which consists of a chair containing an electronic system and software in the back and a coil placed at the head, has been tested on mild to moderate Alzheimer patients who canada goose black friday sale suffer from dementia but are not totally dependent.
The system is in trials at Harvard Medical School/Beth Israel Deaconess Medical Centre. Patients are treated for one hour a day, five days a week over six weeks.
Neuronix CEO Eyal Baror poses for a photo next to a newly developed Cheap Canada Goose Canada Goose Online device to treat Alzheimer’s disease at Assaf Harofeh Medical Center near Tel canada goose clearance sale Aviv October buy canada goose jacket cheap 24, 2012. REUTERS/Nir Elias
see improvement lasting for 9 12 months and the good thing is that patients can uk canada goose return and undergo treatment again, Baror said. canada goose coats out of 10 years the patients have left to live we canada goose store can keep them at home in a relatively mild state of the disease for three, four, five years, it a lot.
According to Alvaro Pascual Leone, Canada Goose Parka director of the hospital Berenson Allen Centre for Non invasive Brain Stimulation, brain stimulation or transcranial magnetic stimulation involves a very low current applied to a specific part of the brain and is approved by the FDA for treatment of a variety of ailments and diagnostic applications.
application in Alzheimer disease and in combination with cognitive training is canadian goose jacket novel, Pascual Leono said in a phone interview from Boston.
Neuronix CEO Eyal Baror (L) sits in the chair of a newly developed device to treat Alzheimer’s disease Canada Goose Outlet during canada goose factory sale a demonstration at Assaf Harofeh Medical Center near Tel Aviv October 24, 2012. REUTERS/Nir Elias
About 20 percent of patients experience a mild headache but there are no long term negative effects, he said.
Pascual Leone, who is principal investigator in the Harvard trial, said that of 12 patients in the study, six received the real treatment and Canada Goose sale all showed cognitive improvement. Their improvement was significantly more than the average seen in patients taking just medication, he said.
The study results will be submitted for publication in the coming weeks and a canada goose coats on sale follow up study on 30 patients is planned.
Neuronix received European approval several canada goose clearance months cheap canada goose uk ago and has installations in the UK and Germany. In Israel, a few dozen patients are being treated with the device.
The company expects to sell half a dozen systems in the second half of 2012 buy canada goose jacket and three dozen in 2013. In Israel, the treatment costs $6,000.
Neuronix has raised cheap Canada Goose $8 million from private individuals as well as in grants from the canada goose Israeli Chief Scientist Office and is exploring options to raise more money in the coming year, including the possibility of canada goose uk outlet going public.
